WEST PHARMACEUTICAL SERVICES, INC. Operating Lease Liability
WEST PHARMACEUTICAL SERVICES, INC. (WST) had Operating Lease Liability of $109.20 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-07-23
- 2026-06-30: Operating Lease, Liability $109.20M.
- 2026-03-31: Operating Lease, Liability $113.40M.
- 2025-12-31: Operating Lease, Liability $118.30M.
- 2025-09-30: Operating Lease, Liability $94.90M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $109.20M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $113.40M 10-Q · filed 2026-04-23 |
| 2025-12-31 | $118.30M 10-K · filed 2026-02-17 |
| 2025-09-30 | $94.90M 10-Q · filed 2025-10-23 |
| 2025-06-30 | $100.70M 10-Q · filed 2025-07-24 |
| 2025-03-31 | $100.60M 10-Q · filed 2025-04-24 |
| 2024-12-31 | $99.70M 10-K · filed 2025-02-18 |
| 2024-09-30 | $102.20M 10-Q · filed 2024-10-24 |
| 2024-06-30 | $104.90M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $100.40M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $102.20M 10-Q · filed 2024-07-25 |
| 2023-09-30 | $99.50M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $103.50M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $106.10M 10-Q · filed 2023-04-27 |
| 2022-12-31 | $109.00M 10-Q · filed 2023-10-26 |
| 2022-09-30 | $90.50M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $80.50M 10-Q · filed 2022-07-28 |
| 2022-03-31 | $78.70M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $72.30M 10-Q · filed 2022-10-27 |
| 2021-09-30 | $61.50M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $65.30M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $66.80M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $70.50M 10-Q · filed 2021-10-28 |
| 2020-09-30 | $69.80M 10-Q · filed 2020-10-23 |
| 2020-06-30 | $70.70M 10-Q · filed 2020-07-24 |
| 2020-03-31 | $70.60M 10-Q · filed 2020-04-24 |
| 2019-12-31 | $72.00M 10-Q · filed 2020-10-23 |
| 2019-09-30 | $73.30M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $76.60M 10-Q · filed 2019-07-29 |
| 2019-03-31 | $77.60M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |